Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2009 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: amlodipine besylate

« Back to Dashboard

Amlodipine besylate is the generic ingredient in eight branded drugs marketed by Synthon Pharms, Accord Hlthcare, Alkem, Amneal Pharms Ny, Apotex, Aurobindo Pharma, Cipla Ltd, Dr Reddys Labs Ltd, Epic Pharma Llc, Gedeon Richter Usa, Genpharm, Hikma Pharms, Invagen Pharms, Lupin, Macleods Pharms Ltd, Matrix Labs Ltd, Mutual Pharma, Mylan, Orchid Hlthcare, Puracap Pharm, Ranbaxy, Roxane, Sandoz, Secan Pharms, Sun Pharm Inds Inc, Teva, Torrent Pharms, Unichem Labs Ltd, Upsher Smith, Vintage, Vivimed Labs, Watson Labs, Wockhardt, Zydus Pharms Usa, Pfizer, Mylan Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Lupin Pharms, Par Pharm, Teva Pharms, Watson Labs Inc, Novartis, Daiichi Sankyo, Lupin Ltd, Torrent Pharms Ltd, Boehringer Ingelheim, and Par Pharm Inc, and is included in thirty-six NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourty-six drug master file entries for amlodipine besylate. Twelve suppliers are listed for this compound. There are eight tentative approvals for this compound.

Summary for Generic Name: amlodipine besylate

Tradenames:8
Patents:14
Applicants:33
NDAs:36
Drug Master File Entries: see list46
Suppliers: see list12

Pharmacology for Ingredient: amlodipine besylate

Tentative approvals for AMLODIPINE BESYLATE

Applicant Application No. Form Dosage
<disabled><disabled>CAPSULE; ORAL5MG; 10MG
<disabled><disabled>CAPSULE; ORAL5MG; 20MG
<disabled><disabled>CAPSULE; ORAL10MG; 20MG

Clinical Trials for: amlodipine besylate

Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
Status: Completed Condition: Hypertension

CKD-330 Drug-Drug Interaction Study (Amlodipine)
Status: Completed Condition: Hypertension

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions
Status: Completed Condition: Healthy

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions
Status: Completed Condition: Healthy

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions
Status: Completed Condition: Healthy

Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
Status: Recruiting Condition: Hypertension

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
CADUET
amlodipine besylate; atorvastatin calcium
TABLET; ORAL021540Jul 29, 2004RXNo6,126,971*PED<disabled><disabled>
Kali Labs Inc
AMLODIPINE BESYLATE
amlodipine besylate
TABLET; ORAL077516Jul 11, 2007RXNo<disabled><disabled>
Pfizer
CADUET
amlodipine besylate; atorvastatin calcium
TABLET; ORAL021540Jan 30, 2004RXNo5,273,995*PED<disabled><disabled>
Novartis
EXFORGE
amlodipine besylate; valsartan
TABLET; ORAL021990Jun 20, 2007RXYes6,294,197*PED<disabled><disabled>
Boehringer Ingelheim
TWYNSTA
amlodipine besylate; telmisartan
TABLET; ORAL022401Oct 16, 2009RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc